156 related articles for article (PubMed ID: 17314924)
1. Application of pharmacogenomic strategies to the study of drug-induced birth defects.
Leeder JS; Mitchell AA
Clin Pharmacol Ther; 2007 Apr; 81(4):595-9. PubMed ID: 17314924
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of cardiovascular defects, part 2: a study based on data from three large registries of congenital malformations.
Harris JA; Francannet C; Pradat P; Robert E
Pediatr Cardiol; 2003; 24(3):222-35. PubMed ID: 12632214
[TBL] [Abstract][Full Text] [Related]
3. Maternal asthma, asthma medication use, and the risk of congenital heart defects.
Lin S; Herdt-Losavio M; Gensburg L; Marshall E; Druschel C
Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):161-8. PubMed ID: 19067406
[TBL] [Abstract][Full Text] [Related]
4. [Neonatal malformations and hormone therapy during pregnancy].
Pacilli L; Graffino W; Arrotta S
Minerva Ginecol; 1981; 33(7-8):659-65. PubMed ID: 7290498
[TBL] [Abstract][Full Text] [Related]
5. Comments on "Cardiovascular birth defects and prenatal exposure to female sex hormones".
Wiseman RA
Teratology; 1994 Mar; 49(3):172-3; discussion 174-7. PubMed ID: 8059423
[No Abstract] [Full Text] [Related]
6. Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics.
Copeland GE; Kirby RS
Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):792-7. PubMed ID: 17990340
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy.
Einarson A; Pistelli A; DeSantis M; Malm H; Paulus WD; Panchaud A; Kennedy D; Einarson TR; Koren G
Am J Psychiatry; 2008 Jun; 165(6):749-52. PubMed ID: 18381907
[TBL] [Abstract][Full Text] [Related]
8. Maternal periconceptional illicit drug use and the risk of congenital malformations.
van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
Epidemiology; 2009 Jan; 20(1):60-6. PubMed ID: 19057385
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular birth defects and prenatal exposure to female sex hormones: importance of utilizing proper epidemiological methods and teratologic principles.
Brent RL
Teratology; 1994 Mar; 49(3):159-61. PubMed ID: 8059420
[No Abstract] [Full Text] [Related]
10. Association between congenital heart defects and small for gestational age.
Malik S; Cleves MA; Zhao W; Correa A; Hobbs CA;
Pediatrics; 2007 Apr; 119(4):e976-82. PubMed ID: 17387169
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant drugs during pregnancy and infant congenital heart defect.
Källén B; Otterblad Olausson P
Reprod Toxicol; 2006 Apr; 21(3):221-2. PubMed ID: 16406480
[No Abstract] [Full Text] [Related]
12. Are there ethnic disparities in risk of preterm birth among infants born with congenital heart defects?
Nembhard WN; Salemi JL; Hauser KW; Kornosky JL
Birth Defects Res A Clin Mol Teratol; 2007 Nov; 79(11):754-64. PubMed ID: 17990335
[TBL] [Abstract][Full Text] [Related]
13. Maternal drugs and congenital heart disease.
Zierler S
Obstet Gynecol; 1985 Feb; 65(2):155-65. PubMed ID: 3881709
[TBL] [Abstract][Full Text] [Related]
14. Severe cardiac and ophthalmologic malformations in an infant exposed to diphenylhydantoin in utero.
Bartoshesky LE; Bhan I; Nagpaul K; Pashayan H
Pediatrics; 1982 Feb; 69(2):202-3. PubMed ID: 7058095
[TBL] [Abstract][Full Text] [Related]
15. Antifungal drugs and the risk of selected birth defects.
Carter TC; Druschel CM; Romitti PA; Bell EM; Werler MM; Mitchell AA;
Am J Obstet Gynecol; 2008 Feb; 198(2):191.e1-7. PubMed ID: 18226621
[TBL] [Abstract][Full Text] [Related]
16. Drug exposure in pregnancy and heart defects.
Matok I; Pupco A; Koren G
J Cardiovasc Pharmacol; 2011 Jul; 58(1):20-4. PubMed ID: 21499119
[TBL] [Abstract][Full Text] [Related]
17. Maternal smoking and congenital heart defects.
Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
[TBL] [Abstract][Full Text] [Related]
18. Maternal use of antipsychotics in early pregnancy and delivery outcome.
Reis M; Källén B
J Clin Psychopharmacol; 2008 Jun; 28(3):279-88. PubMed ID: 18480684
[TBL] [Abstract][Full Text] [Related]
19. Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond.
Leeder JS
Drug Discov Today; 2004 Jul; 9(13):567-73. PubMed ID: 15203092
[TBL] [Abstract][Full Text] [Related]
20. [Alcohol embryopathy].
Leiber B
Dtsch Med Wochenschr; 1978 May; 103(21):880-1. PubMed ID: 565697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
